Sharemarkets on steroids – but not the NZX

Sharemarkets on steroids – but not the NZX
2021 has shown strong performances of global sharemarkets with the exception of the NZX benchmark index. (Image: Deposit Photos)
Brian Gaynor
The first six months of the year has been a great period for global sharemarkets, with the notable exception of the NZX benchmark index.Wall Street has been particularly strong, with the heavily technology weighted Nasdaq up 12.5% since the end of 2020 while the broader based S&P 500 Index appreciated 14.4%. Meanwhile, the ASX benchmark index gained 11% for the six months to June 30 while the NZX50 Capital Index was down 4.5%. The NZX50 Gross Index was off 3.3% for the six months but the capital index has been used in this column for c...

More Opinion

A sweeter deal needed to attract top tech talent
Opinion

Peter Griffin: A sweeter deal needed to attract top tech talent

To attract and retain workers, tech companies need to sweeten equity compensation offers.

How the FMA flies under the regulatory radar
Law & Regulation

David Chaplin: How the FMA flies under the regulatory radar

The FMA has little power to hold back the tide of scammers.

David Chaplin 04 Dec 2024
Tempering great earnings expectations
Markets

Paul McBeth: Tempering great earnings expectations

There’s a lot happening and to look forward to, but NZ is probably still in recession.

Paul McBeth 03 Dec 2024
Labour: The risk of talking to yourself
Opinion

Pattrick Smellie: Labour: The risk of talking to yourself

Labour appears in surprisingly good heart a year after its election defeat.

Pattrick Smellie 02 Dec 2024